BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Santos Apolonio J, Lima de Souza Gonçalves V, Cordeiro Santos ML, Silva Luz M, Silva Souza JV, Rocha Pinheiro SL, de Souza WR, Sande Loureiro M, de Melo FF. Oncolytic virus therapy in cancer: A current review. World J Virol 2021; 10(5): 229-255 [PMID: 34631474 DOI: 10.5501/wjv.v10.i5.229]
URL: https://www.wjgnet.com/2220-3249/full/v10/i5/229.htm
Number Citing Articles
1
Trisha I. Valerio, Coline L. Furrer, Negar Sadeghipour, Sophia-Joy X. Patrock, Sayre A. Tillery, Ashley R. Hoover, Kaili Liu, Wei R. Chen. Immune modulations of the tumor microenvironment in response to phototherapyJournal of Innovative Optical Health Sciences 2023; 16(03) doi: 10.1142/S1793545823300070
2
Izzet Altun, Yusuf M. Demirlenk, Dila Atar, Enes Cevik, Seyda Gunduz, Hassan Albadawi, Rahmi Oklu. Advances and Challenges in Interventional Immuno-Oncology Locoregional TherapiesJournal of Vascular and Interventional Radiology 2024; 35(2): 164 doi: 10.1016/j.jvir.2023.10.009
3
Juri Na, Chul-Hee Lee, June-Key Chung, Hyewon Youn. Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 ExpressionInternational Journal of Molecular Sciences 2023; 24(3): 2761 doi: 10.3390/ijms24032761
4
Jan Sören Eichhorn, Jim Petrik. The tumor microenvironment’s in pancreatic cancer: Effects on immunotherapy success and novel strategies to overcome the hostile environmentPathology - Research and Practice 2024; 259: 155370 doi: 10.1016/j.prp.2024.155370
5
Saru Basnet, Joao M. Santos, Dafne C.A. Quixabeira, James H.A. Clubb, Susanna A.M. Grönberg-Vähä-Koskela, Victor Arias, Santeri Pakola, Tatiana V. Kudling, Camilla Heiniö, Riikka Havunen, Victor Cervera-Carrascon, Suvi Sorsa, Marjukka Anttila, Anna Kanerva, Akseli Hemminki. Oncolytic adenovirus coding for bispecific T cell engager against human MUC-1 potentiates T cell response against solid tumorsMolecular Therapy - Oncolytics 2023; 28: 59 doi: 10.1016/j.omto.2022.12.007
6
Muhammad Ikrama, Muhammad Usama. Oncolytic virotherapy in gastric cancer: Towards precision therapeuticsGastroenterology & Endoscopy 2024; 2(2): 79 doi: 10.1016/j.gande.2024.03.006
7
Roderick C. McDowell, Jordhan D. Booth, Allyson McGowan, Wojciech Kolodziejczyk, Glake A. Hill, Santanu Banerjee, Manliang Feng, Karina Kapusta. Computational Approach for the Development of pH-Selective PD-1/PD-L1 Signaling Pathway Inhibition in Fight with CancerCancers 2024; 16(13): 2295 doi: 10.3390/cancers16132295
8
Hao Lin, Chaxian Liu, Ankang Hu, Duanwu Zhang, Hui Yang, Ying Mao. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectivesJournal of Hematology & Oncology 2024; 17(1) doi: 10.1186/s13045-024-01544-7
9
Daniel Sausen, Oren Shechter, Elisa Gallo, Harel Dahari, Ronen Borenstein. Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment ImplicationsCancers 2023; 15(14): 3692 doi: 10.3390/cancers15143692
10
Yan-Ruide Li, Zibai Lyu, Yanxin Tian, Ying Fang, Yichen Zhu, Yuning Chen, Lili Yang. Advancements in CRISPR screens for the development of cancer immunotherapy strategiesMolecular Therapy - Oncolytics 2023; 31: 100733 doi: 10.1016/j.omto.2023.100733
11
Arianna Mayorga-Ramos, Johana Zúñiga-Miranda, Saskya E. Carrera-Pacheco, Carlos Barba-Ostria, Linda P. Guamán. CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of ResistanceACS Infectious Diseases 2023; 9(7): 1283 doi: 10.1021/acsinfecdis.2c00649
12
Saurabh Gautam, Dongyue Xin, Alan Pardo Garcia, Bart Spiesschaert. Single-step rapid chromatographic purification and characterization of clinical stage oncolytic VSV-GPFrontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.992069
13
Sandra Pelka, Chandan Guha. Enhancing Immunogenicity in Metastatic Melanoma: Adjuvant Therapies to Promote the Anti-Tumor Immune ResponseBiomedicines 2023; 11(8): 2245 doi: 10.3390/biomedicines11082245
14
Nikita Mundhara, Pritam Sadhukhan. Cracking the Codes behind Cancer Cells’ Immune EvasionInternational Journal of Molecular Sciences 2024; 25(16): 8899 doi: 10.3390/ijms25168899
15
Zinnia P. Parra‐Guillen, Aymara Sancho‐Araiz, Kapil Mayawala, Sara Zalba, Maria J. Garrido, Dinesh de Alwis, Iñaki F. Troconiz, Tomoko Freshwater. Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically‐Based ModelingClinical Pharmacology & Therapeutics 2023; 114(3): 623 doi: 10.1002/cpt.2937
16
Chun Fang Shen, Elodie Burney, Rénald Gilbert, S. Mehdy Elahi, Kelley Parato, Martin Loignon. Development, optimization, and scale‐up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus‐1Biotechnology Journal 2024; 19(1) doi: 10.1002/biot.202300244
17
Sabrina DeStefano, Daphna Fertil, Mondreakest Faust, Kaitlyn Sadtler. Basic immunologic study as a foundation for engineered therapeutic developmentPharmacology Research & Perspectives 2024; 12(4) doi: 10.1002/prp2.1168
18
Karen Geoffroy, Mélissa Viens, Emma Mary Kalin, Zied Boudhraa, Dominic Guy Roy, Jian Hui Wu, Diane Provencher, Anne-Marie Mes-Masson, Marie-Claude Bourgeois-Daigneault. The Small GTPase Ran Increases Sensitivity of Ovarian Cancer Cells to Oncolytic Vesicular Stomatitis VirusPharmaceuticals 2024; 17(12): 1662 doi: 10.3390/ph17121662
19
Anurag S. Rathore, Narendra Chirmule, Rozaleen Dash, Anandi Chowdhury. Immunology for EngineersAdvances in Protein Chemistry and Structural Biology 2024; 140: 293 doi: 10.1016/bs.apcsb.2023.12.006
20
Anita Silas La’ah, Shih-Hwa Chiou. Cutting-Edge Therapies for Lung CancerCells 2024; 13(5): 436 doi: 10.3390/cells13050436
21
Bo-Kyoung Jung, Yong Hee An, Sung Hoon Jang, Jin-Ju Jang, Seonhee Kim, Joo Hee Jeon, Jinju Kim, Jason Jungsik Song, Hyun Jang. The artificial amino acid change in the sialic acid-binding domain of the hemagglutinin neuraminidase of newcastle disease virus increases its specificity to HCT 116 colorectal cancer cells and tumor suppression effectVirology Journal 2024; 21(1) doi: 10.1186/s12985-023-02276-9
22
Vijay Kumar, John H. Stewart. Interdisciplinary Cancer Research 2024;  doi: 10.1007/16833_2024_440
23
Prateek Suresh Harne, Vaishali Harne, Curtis Wray, Nirav Thosani. Endoscopic innovations in diagnosis and management of pancreatic cancer: a narrative review and future directionsTherapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241297434
24
Kaoutar Bentayebi, Rim El Aked, Oumaima Ezzahidi, Alae Bekkouri Alami, Sara Louati, Mouna Ouadghiri, Tarik Aanniz, Saaïd Amzazi, Lahcen Belyamani, Azzedine Ibrahimi, Keittisak Suwan, Amin Hajitou, Rachid Eljaoudi. Targeting molecular mechanisms underlying treatment efficacy and resistance in DIPG: A review of current and future strategiesBrain Disorders 2024; 14: 100132 doi: 10.1016/j.dscb.2024.100132
25
Vahideh Hamidi-Sofiani, Reza Rakhshi, Niloufar Moradi, Parisa Zeynali, Mohsen Nakhaie, Emad Behboudi. Oncolytic viruses and pancreatic cancerCancer Treatment and Research Communications 2022; 31: 100563 doi: 10.1016/j.ctarc.2022.100563
26
Lin Fang, Weiping Tian, Chen Zhang, Xueyan Wang, Wanjing Li, Qi Zhang, Yuxin Zhang, Junnian Zheng. Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinomaPharmacological Research 2023; 189: 106701 doi: 10.1016/j.phrs.2023.106701
27
Cristina Díaz del Arco. Interdisciplinary Cancer Research 2024;  doi: 10.1007/16833_2024_202
28
Geng-Hao Bai, Sheng-Chieh Lin, Yi-Hsiang Hsu, Shih-Yen Chen. The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic ApplicationsViruses 2022; 14(2): 278 doi: 10.3390/v14020278
29
Federica Li Pomi, Francesco Borgia, Paolo Custurone, Mario Vaccaro, Giovanni Pioggia, Sebastiano Gangemi. Role of HMGB1 in Cutaneous Melanoma: State of the ArtInternational Journal of Molecular Sciences 2022; 23(16): 9327 doi: 10.3390/ijms23169327
30
Maryam Sadri, Alireza Najafi, Ali Rahimi, Nafiseh Behranvand, Mohammad Hossein Kazemi, Hossein Khorramdelazad, Reza Falak. Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?International Immunopharmacology 2023; 122: 110470 doi: 10.1016/j.intimp.2023.110470
31
Estanislao Nistal-Villan, Sergio Rius-Rocabert, Francisco Llinares-Pinel. Viral Vectors in Cancer ImmunotherapyInternational Review of Cell and Molecular Biology 2023; 379: 221 doi: 10.1016/bs.ircmb.2023.05.004
32
Zizhao Mai, Yunfan Lin, Pei Lin, Xinyuan Zhao, Li Cui. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapyCell Death & Disease 2024; 15(5) doi: 10.1038/s41419-024-06697-4
33
Ela Guo, Hana M. Dobrovolny. Mathematical Modeling of Oncolytic Virus Therapy Reveals Role of the Immune ResponseViruses 2023; 15(9): 1812 doi: 10.3390/v15091812
34
Qing Ji, Yuchen Wu, Andreas Albers, Meiyu Fang, Xu Qian. Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical ApproachesPharmaceutics 2022; 14(9): 1811 doi: 10.3390/pharmaceutics14091811
35
Luying Pan, Johanna Mora, Karl Walravens, Leslie Wagner, Shirley Hopper, Lina Loo, David Bettoun, Sarah Bond, Francis Dessy, Sean Downing, Fabio Garofolo, Soumi Gupta, Neil Henderson, Chad Irwin, Akiko Ishii-Watabe, Sumit Kar, Vibha Jawa, Julie Joseph, Ludovic Malvaux, Jean-Claude Marshall, Jessica McDevitt, Susovan Mohapatra, Jessica Seitzer, Justin Smith, Therese Solstad, Hiroshi Sugimoto, Omar Tounekti, Bonnie Wu, Yuling Wu, Yuanxin Xu, Joshua Xu, Takenori Yamamoto, Lin Yang, Albert Torri, Susan Kirshner, Kimberly Maxfield, Joao Pedras Vasconcelos, Mohsen Rajabi Abhari, Daniela Verthelyi, Eric Brodsky, Montserrat Carrasco-Triguero, John Kamerud, Matthew Andisik, Daniel Baltrukonis, Nicoletta Bivi, Isabelle Cludts, Kelly Coble, Boris Gorovits, George R Gunn, Swati Gupta, Anders Holm Millner, Alison Joyce, Robert J Kubiak, Seema Kumar, Karen Liao, Mohanraj Manangeeswaran, Michael Partridge, Samuel Pine, Johann Poetzl, Manoj Rajadhyaksha, Michele Rasamoelisolo, Susan Richards, Yuan Song, Steven Swanson, Seth Thacker, Meenu Wadhwa, Andreas Wolf, Lucia Zhang, Lin Zhou. 2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolongation Effect, Ada Affinity, Risk-Based Approaches, Ngs, Qpcr, Ddpcr Assays ( Part 3 – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Immunogenicity & Risk Assessment of Biotherapeutics and Novel Modalities; NAb Assays Integrated Approach) Bioanalysis 2023; 15(14): 773 doi: 10.4155/bio-2023-0135
36
Kay Hänggi, Brian Ruffell. Cell death, therapeutics, and the immune response in cancerTrends in Cancer 2023; 9(5): 381 doi: 10.1016/j.trecan.2023.02.001
37
Shanying Huang, Haiyan Hu, Guoling Tang, Kai Liu, Zhihua Luo, Weiwei Zeng. An oncolytic herpes simplex virus type 1 strain expressing a single-chain variable region antibody fragment against PD-1 and a PI3K inhibitor synergize to elicit antitumor immunity in ovarian cancerArchives of Virology 2023; 168(4) doi: 10.1007/s00705-023-05754-1
38
Samriti Dhawan, Vishal Sharma, Jagdeep Kaur. Molecular Biomarkers for Cancer Diagnosis and Therapy2024; : 537 doi: 10.1007/978-981-99-3746-2_26
39
Jingyu Zhang, Jiahe Chen, Kezhi Lin. Immunogenic cell death-based oncolytic virus therapy: A sharp sword of tumor immunotherapyEuropean Journal of Pharmacology 2024; 981: 176913 doi: 10.1016/j.ejphar.2024.176913
40
Thi Kim Anh Nguyen, Huu-Thinh Nguyen, Sao-Mai Dam. Cancer Treatment: An Interdisciplinary ApproachInterdisciplinary Cancer Research 2023; 2: 47 doi: 10.1007/16833_2023_135
41
Palaniyandi Muthukutty, So Young Yoo. Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy PerspectiveViruses 2023; 15(8): 1645 doi: 10.3390/v15081645
42
Junhe Zhang, Yunxi Xiao, Jie Zhang, Yun Yang, Liao Zhang, Fan Liang. Recent advances of engineered oncolytic viruses-based combination therapy for liver cancerJournal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-023-04817-w
43
Assia Angelova, Milena Barf, Alexandra Just, Barbara Leuchs, Jean Rommelaere, Guy Ungerechts. H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell LymphomaCancers 2024; 16(15): 2711 doi: 10.3390/cancers16152711
44
Wenmo Liu, Xupu Wang, Xinyao Feng, Jiahao Yu, Xinyao Liu, Xinyuan Jia, Haihong Zhang, Hui Wu, Chu Wang, Jiaxin Wu, Bin Yu, Xianghui Yu. Oncolytic adenovirus-mediated intratumoral expression of TRAIL and CD40L enhances immunotherapy by modulating the tumor microenvironment in immunocompetent mouse modelsCancer Letters 2022; 535: 215661 doi: 10.1016/j.canlet.2022.215661
45
Mohamed E. Elnosary, Fatma K. Salem, Omar Mohamed, Mahmoud A. Elbas, Adel A. Shaheen, Magdy T. Mowafy, Ibrahim E. Ali, Aya Tawfik, Ahmed A. Hmed, Ehab E. Refaey, Esmat M. Esmat, Ahmed R. Sofy. Unlocking the potential: a specific focus on vesicular stomatitis virus as a promising oncolytic and immunomodulatory agent in cancer therapyDiscover Medicine 2024; 1(1) doi: 10.1007/s44337-024-00082-y
46
Hui Ma, Qing-Zhu Yan, Jing-Ru Ma, Dong-Fu Li, Jun-Ling Yang. Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategiesWorld Journal of Gastroenterology 2024; 30(10): 1295-1312 doi: 10.3748/wjg.v30.i10.1295
47
Thomas Karadimas, Thien Huong Huynh, Chloe Chose, Guston Zervoudakis, Bryan Clampitt, Sean Lapp, David Joyce, George Douglas Letson, Jonathan Metts, Odion Binitie, John E. Mullinax, Alexander Lazarides. Oncolytic Viral Therapy in OsteosarcomaViruses 2024; 16(7): 1139 doi: 10.3390/v16071139
48
Dushyant Singh Dahiya, Saurabh Chandan, Hassam Ali, Bhanu Siva Mohan Pinnam, Manesh Kumar Gangwani, Hashem Al Al Bunni, Andrew Canakis, Harishankar Gopakumar, Ishaan Vohra, Jay Bapaye, Mohammad Al-Haddad, Neil R. Sharma. Role of Therapeutic Endoscopic Ultrasound in Management of Pancreatic Cancer: An Endoscopic Oncologist PerspectiveCancers 2023; 15(12): 3235 doi: 10.3390/cancers15123235
49
Mason J. Webb, Ugur Sener, Richard G. Vile. Current Status and Challenges of Oncolytic Virotherapy for the Treatment of GlioblastomaPharmaceuticals 2023; 16(6): 793 doi: 10.3390/ph16060793
50
Henry Sossa-Rojas, Pedro Gabriel Franco-Maz, Carlos Manuel Zapata-Acevedo, Carlos Arturo Guerrero-Fonseca. Cultivo de explantes de adenocarcinoma gástrico humano: Modelo para la evaluación de la actividad oncolítica del rotavirus Wt1-5Revista de la Facultad de Medicina 2023; 71(3): e105765 doi: 10.15446/revfacmed.v71n3.105765
51
Daniel Meraviglia-Crivelli, Angelina Zheleva, Martin Barainka, Beatriz Moreno, Helena Villanueva, Fernando Pastor. Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune SystemBiomedicines 2022; 10(8): 1842 doi: 10.3390/biomedicines10081842
52
Supaporn Numpadit, Chiaki Ito, Takaaki Nakaya, Katsuro Hagiwara. Investigation of oncolytic effect of recombinant Newcastle disease virus in primary and metastatic oral melanomaMedical Oncology 2023; 40(5) doi: 10.1007/s12032-023-02002-z
53
Anke Brüning-Richardson. Cell Migration in Development, Health and DiseaseLearning Materials in Biosciences 2024; : 277 doi: 10.1007/978-3-031-64532-7_13
54
Shiyu Liu, Fan Li, Li Deng, Qiongqiong Ma, Wenyi Lu, Zhuoqian Zhao, Huanzhen Liu, Yixuan Zhou, Manli Hu, Hui Wang, Yingbin Yan, Mingfeng Zhao, Hongkai Zhang, Mingjuan Du. Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancerMolecular Therapy - Oncolytics 2023; 30: 275 doi: 10.1016/j.omto.2023.08.011
55
Francisca Cristi, Tomás Gutiérrez, Mary M. Hitt, Maya Shmulevitz. Genetic Modifications That Expand Oncolytic Virus PotencyFrontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.831091
56
Aatiya Ahmad, Parvez Khan, Asad Ur Rehman, Surinder Kumar Batra, Mohd Wasim Nasser. Immunotherapy: an emerging modality to checkmate brain metastasisMolecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01818-7
57
Mingjing Deng, Qi Wang. Research Advances of Clinical Application of Oncolytic Viruses in Treatment of Gynecologic CancersCurrent Cancer Drug Targets 2023; 23(7): 505 doi: 10.2174/1568009623666230221154415
58
Ryan Kilgore, Arianna Minzoni, Shriarjun Shastry, Will Smith, Eduardo Barbieri, Yuxuan Wu, Jacob P. LeBarre, Wenning Chu, Juliana O'Brien, Stefano Menegatti. The downstream bioprocess toolbox for therapeutic viral vectorsJournal of Chromatography A 2023; 1709: 464337 doi: 10.1016/j.chroma.2023.464337
59
Samagra Jain, Rahul A. Sheth. Modulating the tumor immune microenvironment with locoregional image-guided interventionsFrontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1057597
60
M. Vindhya, M. N. Ramesh Bharadwaj, Kanthesh M. Basalingappa, T. S. Gopenath, Ashok Gnanasekaran. Targeted Cancer Therapy in Biomedical EngineeringBiological and Medical Physics, Biomedical Engineering 2023; : 179 doi: 10.1007/978-981-19-9786-0_5
61
Monika A. Papież, Wirginia Krzyściak. Biological Therapies in the Treatment of Cancer—Update and New DirectionsInternational Journal of Molecular Sciences 2021; 22(21): 11694 doi: 10.3390/ijms222111694
62
Mason J. Webb, Thanich Sangsuwannukul, Jacob van Vloten, Laura Evgin, Benjamin Kendall, Jason Tonne, Jill Thompson, Muriel Metko, Madelyn Moore, Maria P. Chiriboga Yerovi, Michael Olin, Antonella Borgatti, Mark McNiven, Satdarshan P. S. Monga, Mitesh J. Borad, Alan Melcher, Lewis R. Roberts, Richard Vile. Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell responseNature Communications 2024; 15(1) doi: 10.1038/s41467-024-49286-x
63
Surya K. De. Medicines for Cancer2023; : 489 doi: 10.1016/B978-0-443-13312-1.00001-5
64
Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan. mRNA vaccines for cancer immunotherapyFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1029069
65
Prathibha Ambegoda-Liyanage, Sophia R.-J. Jang. Resistance in oncolytic viral therapy for solid tumorsApplied Mathematics and Computation 2024; 469: 128546 doi: 10.1016/j.amc.2024.128546
66
Sangiliyandi Gurunathan, Pratheep Thangaraj, Lin Wang, Qilong Cao, Jin-Hoi Kim. Nanovaccines: An effective therapeutic approach for cancer therapyBiomedicine & Pharmacotherapy 2024; 170: 115992 doi: 10.1016/j.biopha.2023.115992
67
Amirhossein Bahreyni, Huitao Liu, Yasir Mohamud, Yuan Chao Xue, Jingchun Zhang, Honglin Luo. A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent miceCancer Letters 2022; 548: 215849 doi: 10.1016/j.canlet.2022.215849
68
Firas Batrash, Adnan Shaik, Rayaan Rauf, Mahmoud Kutmah, Jun Zhang. Paracrine Regulation and Immune System Pathways in the Inflammatory Tumor Microenvironment of Lung Cancer: Insights into Oncogenesis and Immunotherapeutic StrategiesCancers 2024; 16(6): 1113 doi: 10.3390/cancers16061113
69
Gunjan Dagar, Ashna Gupta, Tariq Masoodi, Sabah Nisar, Maysaloun Merhi, Sheema Hashem, Ravi Chauhan, Manisha Dagar, Sameer Mirza, Puneet Bagga, Rakesh Kumar, Ammira S. Al-Shabeeb Akil, Muzafar A. Macha, Mohammad Haris, Shahab Uddin, Mayank Singh, Ajaz A. Bhat. Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatmentsJournal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04292-3
70
Daciana Elena Brănişteanu, Elena Porumb-Andrese, Vlad Porumb, Alexandra Stărică, Andreea Dana Moraru, Alin Codruț Nicolescu, Mihail Zemba, Cătălina Ioana Brănişteanu, George Brănişteanu, Daniel Constantin Brănişteanu. New Treatment Horizons in Uveal and Cutaneous MelanomaLife 2023; 13(8): 1666 doi: 10.3390/life13081666
71
Isabela Granha, Gustavo Sartorelli, Oswaldo Keith Okamoto, Elisa Helena Farias Jandrey. Emergent and underexplored oncolytic viruses for treating pediatric central nervous system tumorsEJC Paediatric Oncology 2024; 3: 100151 doi: 10.1016/j.ejcped.2024.100151
72
Babak Arjmand, Sepideh Alavi-Moghadam, Golnar Khorsand, Maedeh Sarvari, Rasta Arjmand, Mostafa Rezaei-Tavirani, Mohsen Rajaeinejad, Reza Mosaed. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer TreatmentRegenerative Engineering and Translational Medicine 2024; 10(4): 480 doi: 10.1007/s40883-024-00338-0
73
G. V. R. K. Vithanage, Sophia R-J Jang. Optimal Immunotherapy of Oncolytic Viruses and Adopted Cell Transfer in Cancer TreatmentWSEAS TRANSACTIONS ON BIOLOGY AND BIOMEDICINE 2022; 19: 140 doi: 10.37394/23208.2022.19.15
74
Georgios M. Stergiopoulos, Ianko Iankov, Evanthia Galanis. Personalizing Oncolytic Immunovirotherapy ApproachesMolecular Diagnosis & Therapy 2024; 28(2): 153 doi: 10.1007/s40291-023-00689-4
75
Suyog Shaha, Danika Rodrigues, Samir Mitragotri. Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translationJournal of Controlled Release 2024; 367: 737 doi: 10.1016/j.jconrel.2024.01.072
76
Xin Wang, Jia He, Minmin Sun, Shiwan Wang, Jinxiu Qu, Hanping Shi, Benqiang Rao. High-dose vitamin C as a metabolic treatment of cancer: a new dimension in the era of adjuvant and intensive therapyClinical and Translational Oncology 2024;  doi: 10.1007/s12094-024-03553-x
77
Tiancheng Xu, Lei Yu, Yajuan Cao, Binghua Li, Yunzheng Li, Laizhu Zhang, Decai Yu. Apolipoprotein A1-encoding recombinant adenovirus remodels cholesterol metabolism in tumors and the tumor microenvironment to inhibit hepatocellular carcinomaTranslational Research 2025; 275: 18 doi: 10.1016/j.trsl.2024.10.003
78
Khandoker Usran Ferdous, Mulu Z. Tesfay, Aleksandra Cios, Randal S. Shelton, Conner Hartupee, Alicja Urbaniak, Jean Christopher Chamcheu, Michail N. Mavros, Emmanouil Giorgakis, Bahaa Mustafa, Camila C. Simoes, Isabelle R. Miousse, Alexei G. Basnakian, Omeed Moaven, Steven R. Post, Martin J. Cannon, Thomas Kelly, Bolni Marius Nagalo. Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic CancerBiomedicines 2024; 12(7): 1596 doi: 10.3390/biomedicines12071596
79
Aritraa Lahiri, Avik Maji, Pravin D. Potdar, Navneet Singh, Purvish Parikh, Bharti Bisht, Anubhab Mukherjee, Manash K. Paul. Lung cancer immunotherapy: progress, pitfalls, and promisesMolecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01740-y
80
Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya, Anthony K. Park, Sang-In Kim, Jianming Lu, Hannah Valencia, Yuman Fong, Yanghee Woo. Anti-Tumor Immunogenicity of the Oncolytic Virus CF33-hNIS-antiPDL1 against Ex Vivo Peritoneal Cells from Gastric Cancer PatientsInternational Journal of Molecular Sciences 2023; 24(18): 14189 doi: 10.3390/ijms241814189
81
Palaniyandi Muthukutty, Hyun Woo, Murali Ragothaman, So Yoo. Recent Advances in Cancer Immunotherapy Delivery ModalitiesPharmaceutics 2023; 15(2): 504 doi: 10.3390/pharmaceutics15020504
82
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, Hensin Tsao. Recent progress in cancer vaccines and nanovaccinesBiomaterials 2025; 314: 122856 doi: 10.1016/j.biomaterials.2024.122856
83
Kannan Raja. Comments on “Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses”Oral Oncology 2024; 155: 106897 doi: 10.1016/j.oraloncology.2024.106897
84
Ted Kim, Nam Q. Bui. The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted TherapiesCancers 2023; 15(6): 1692 doi: 10.3390/cancers15061692
85
Lin Fang, Weiping Tian, Chen Zhang, Xueyan Wang, Wanjing Li, Qi Zhang, Yuxin Zhang, Junnian Zheng. Oncolytic Adenovirus-Mediated Expression of CCL5 and IL12 Facilitates CA9-Targeting CAR-T Therapy Against Renal Cell CarcinomaSSRN Electronic Journal 2022;  doi: 10.2139/ssrn.4201217
86
Archita Rai, Swati G Deshpande, Ashish Vaidya, Raju K Shinde. Advancements in Immunotherapy for Breast Cancer: Mechanisms, Efficacy, and Future DirectionsCureus 2024;  doi: 10.7759/cureus.68351